Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
US Army
Chinese Patent Office

Generated: February 21, 2018

DrugPatentWatch Database Preview

Ingredient-type: Sulfonamides

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
LannettACETAZOLAMIDEacetazolamideTABLET;ORAL084840-001Approved Prior to Jan 1, 1982ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Heritage Pharms IncACETAZOLAMIDEacetazolamideCAPSULE, EXTENDED RELEASE;ORAL090779-001Jul 14, 2011ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Heritage PharmaACETAZOLAMIDEacetazolamideTABLET;ORAL205530-001Oct 27, 2016ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Novast Labs LtdACETAZOLAMIDEacetazolamideCAPSULE, EXTENDED RELEASE;ORAL203434-001Sep 30, 2016ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Zydus Pharms Usa IncACETAZOLAMIDEacetazolamideCAPSULE, EXTENDED RELEASE;ORAL040904-001Dec 10, 2008ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
TaroACETAZOLAMIDEacetazolamideTABLET;ORAL040195-001May 28, 1997ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Heritage PharmaACETAZOLAMIDEacetazolamideTABLET;ORAL205530-002Oct 27, 2016ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
TaroACETAZOLAMIDEacetazolamideTABLET;ORAL040195-002May 28, 1997ABRXNoYes➤ Sign Up➤ Sign Up➤ Sign Up
Strides PharmaACETAZOLAMIDEacetazolamideTABLET;ORAL209734-001Nov 20, 2017ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Nostrum Labs IncACETAZOLAMIDEacetazolamideCAPSULE, EXTENDED RELEASE;ORAL204691-001Mar 29, 2016ABRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: